Anti-lymphocytic antibody and autoimmune disease: a review.
D000820:Animal Diseases / Q000188:drug therapy; D000818:Animals; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003165:Complement System Proteins / Q000032:analysis; D004285:Dogs; D004357:Drug Synergism; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007106:Immune Sera; D007109:Immunity; D007249:Inflammation / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008198:Lymph Nodes / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D051381:Rats; D013154:Spleen / Q000187:drug effects; D013950:Thymus Gland / Q000187:drug effects; D014181:Transplantation Immunology; D014777:Virus Diseases / Q000188:drug therapy
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007106:Immune Sera; D003165:Complement System Proteins